查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1179910

2023-2030 年全球 NIBP（無創血壓）市場

Global Non-Invasive Blood Pressure Monitors Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內（2023-2030 年），NIBP（無創血壓）的全球市場規模預計將以 7.0% 的複合年增長率增長。

血壓計在醫院中用於測量危重病人和接受手術的病人的血壓。 血壓計用於手術室、重症監護病房、手術恢復室、急診室和其他重症監護區域，以定期或連續測量血壓。 血壓在診斷中起著重要作用，因此在患者病情危重時進行檢查。

市場動態

全球對高血壓和心血管疾病的控制和政府控制、老年人口增加以及 NIBP（無創血壓）計的技術進步是預測期內推動市場的因素。.

對 NIBP（無創血壓）的持續研究有望推動市場增長。

BPro（Healthstats，新加坡）是一款用於動態血壓測量的腕式橈動脈壓力監測儀。 最初使用上臂袖帶裝置進行校準。 本表將在校准後至少 24 小時內提供準確結果。 該設備由一個帶有簡單圖形用戶界面的表頭和一個壓在橈動脈上的柱塞組成。 柱塞由校準醫療保健專業人員用膠帶固定在手腕上，以確保它在使用過程中不會移動。 根據 AAMI 和 ESH 標準，該設備已經過驗證，可以分別將 SBP 和 DBP 測量到 (0.9 7.6) mmHg 和 (1.1 6.1) mmHg。

此外，圖爾庫大學的一個研究小組在 2020 年提出了一種桌面型血壓計，即手指動脈無創張力計監測儀 (FANTOM)。 使用眼壓計無袖口機電系統，對指尖施加壓力並測量示波法血壓。 可以測量動脈波形和中心血壓 (CBP)。 將此設備與自動手臂袖帶監測器進行比較的可選驗證協議產生的 SBP 和 DBP 結果分別為 (0.9 7.3) mmHg 和 (3.3 6.6) mmHg。 因此，無袖帶無創血壓 (NIBP) 的研究進展有望成為預測期內的推動力。

無創血壓測量的缺點預計會阻礙市場增長。

無創血壓測量在極端壓力下不可靠，並且無法進行連續監測。 此外，將其設置為過於頻繁地重複可能會很痛苦，並且需要手動干預才能獲得最大的準確性（即自動模式在不穩定的患者中不可靠）。 因此，預計上述因素將在預測期內阻礙市場。

COVID-19 影響分析

COVID-19 大流行對 NIBP（無創血壓）市場產生了一定影響。 當 COVID-19 病例開始在全球範圍內上升時，專家們意識到這對患有心髒病和相關疾病（尤其是高血壓）的人來說尤其危險。 在美國，有 1.03 億人（約佔成年人的一半）患有高血壓（也稱為高血壓）。 更糟糕的是，只有四分之一的成年人的血壓得到控制。 不受控制的血壓會導致嚴重的並發症，例如心髒病發作和中風。 隨著 COVID-19 流行病的持續，新的問題又出現了。 患有高血壓的人可能更容易受到更致命和更嚴重的冠狀病毒副作用的影響。 因此，對無創血壓計的需求越來越大。

此外，COVID-19 還有另一個潛在的有害影響。 由於擔心感染冠狀病毒，許多患者正在避開當地醫院和急診室。 全國各地的醫院報告說，因緊急醫療需求前來就診的患者越來越少。 但一些專家認為，這並不是因為患者拖延或拖延治療，而是因為病例數在下降。 因此，預計市場將在預測期內受到上述因素的影響和改善。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 對 NIBP（無創血壓）監測儀的持續研究有望推動市場增長。
    • 約束因素
      • 無創血壓測量的缺點預計會阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 搬運工的五種力量
  • 供應鏈
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按設備類型

  • 自動血壓計
  • 門診血壓計
  • 血壓計
  • 血壓傳感器

第八章技術

  • 數字
  • 無液液體
  • 可穿戴設備

第9章配件

  • 血壓計
  • 壓力計
  • 閥門和管道
  • 閥門

第 10 章最終用戶

  • 醫院
  • 診所
  • 門診手術中心
  • 家庭醫療
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第13章公司簡介

  • GE Healthcare
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • SOMNOmedics
  • Eccosur SA
  • Koninklijke Philips N.V.
  • Huntleigh Technology Ltd.
  • Mortara Instrument
  • Schiller Americans Inc.
  • American Diagnostic Corporation
  • Welch Allyn

第 14 章全球 NIBP（無創血壓）市場數據 M

簡介目錄
Product Code: DMMD56

Market Overview

The global non-invasive blood pressure monitors market size was valued US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 7.0% during the forecast period (2023-2030).

Blood pressure monitors are used in hospitals to measure the blood pressure of patients who are critically ill or will be operated on for any surgical procedure. Blood pressure monitors are used in the operating room, intensive care units, surgical recovery rooms, emergency departments, and other critical care areas to measure blood pressure regularly or continuously. Blood pressure is checked during a patient's critical condition because it plays an important role in diagnosis.

Market Dynamics

The global rise of hypertension and cardiovascular diseases and governmental control, the rising geriatric population, and technological advancement in non-invasive blood pressure monitors are the factors to drive the market in the forecast period.

Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.

BPro (Healthstats, Singapore) is a wristwatch radial artery tonometer for ambulatory blood pressure measurement. It is calibrated with a brachial cuff device at first. The watch provides accurate results for at least 24 hours after calibration. The device comprises a watch head with a simple graphic user interface and a plunger to be pressed against the radial artery. The plunger is taped to the wrist by the healthcare professional performing the calibration to prevent it from moving while in use. The device has been validated in accordance with the AAMI and ESH standards, with SBP and DBP readings of (0.9 7.6) mmHg and (1.1 6.1) mmHg, respectively.

Furthermore, in 2020, a research group at the University of Turku proposed a tabletop form factor blood pressure instrument, the finger artery non-invasive tonooscillometric monitor (FANTOM). A tonometric cuffless mechatronic system is used to apply pressure to the fingertip and measure blood pressure using an oscillometric method. The device can measure arterial waveforms and central blood pressure (CBP). An arbitrary validation protocol comparing the device to an automated arm cuff monitor produced SBP and DBP results of (0.9 7.3) mmHg and (3.3 6.6) mmHg, respectively. Therefore, the ongoing research for cuffless non-invasive blood pressure monitors is expected to drive in the forecast period.

Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.

Non-invasive blood pressure measurement is less reliable at pressure extremes, and continuous monitoring is not possible; it can be painful if set to repeat too frequently and requires manual operation for maximum accuracy (i.e., automatic modes are unreliable in unstable patients). Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has impacted the non-invasive blood pressure monitors market moderately. Experts realized that COVID-19 was especially dangerous for people with heart disease and related conditions, especially high blood pressure when cases of the virus started to rise globally. One hundred three million adults in the United States, or nearly half of all adults, have high blood pressure, also referred to as hypertension. Even more concerning is the fact that only 1 in 4 adults have their blood pressure under control. Uncontrolled blood pressure can result in severe complications like heart attack and stroke. As COVID-19 outbreaks persisted, a new issue surfaced. High blood pressure sufferers may be susceptible to more fatal and severe coronavirus side effects. As a result, there is now more of a demand for non-invasive blood pressure monitors.

In addition, COVID-19 has another potentially harmful effect. It has caused many patients to avoid their local hospitals and emergency rooms because they might contract the coronavirus. Hospitals across the nation are reporting a decrease in visits for urgent medical needs. Still, some experts think this isn't because patients are experiencing fewer of them rather than because they are putting off or postponing seeking treatment. Thus, from the above factors, the market got affected and is expected to improve in the forecast period.

Segment Analysis

Digital segment is expected to hold the largest market share in non-invasive blood pressure monitors

The digital segment accounted for the largest market share in 2021. The convenience that a digital blood pressure monitor provides in its mode of operation. They are ideal for use at home, particularly if the patient takes blood pressure readings. They employ electronic pressure sensors to assist in the measurement of blood pressure. As a result, readings are displayed digitally on a screen. A digital blood pressure monitor will help save time. It will save the patient from paying unnecessary fees to doctors who help you monitor their blood pressure. While most are battery-powered, some models are designed for field use and have dual power sources, including solar and battery cells.

Furthermore, digital blood pressure monitors are an excellent choice for people who have hearing or vision impairments. Some even provide paper printouts to assist you in keeping records. This helps your doctor evaluate your health at your next appointment. Therefore, it has increased the demand for digital non-invasive blood pressure monitors. Thus, from the above factors, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global non-invasive blood pressure monitors market

North America region accounted for the largest market share in 2021. The rising geriatric population, rising incidence of hypertension, increasing prevalence of cardiovascular disease, technological advancement in non-invasive blood pressure monitors, and product launches by the market players are the factors driving market growth in the forecast period. For instance, according to the Centers for Disease Control and Prevention, Hypertension increases the risk of heart disease and stroke, which are the leading causes of death in the United States. Hypertension was a primary or contributing cause of more than 670,000 deaths in the United States in 2020. Only about one in every four adults (24%) has hypertension under control. Uncontrolled hypertension affects roughly half of all adults (45%), with a blood pressure of 140/90 mmHg or higher. This includes 37 million adults in the United States.

Furthermore, On August 31, 2022, Sensifree LTD received a CE certificate for SentiCor-100 in compliance with the new EU MDR. SentiCor-100 is the world's first PPG-based Continuous Non-Invasive Blood Pressure (cNIBP) monitoring device approved for hospital use. Thus, from the above factors, the North American region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the non-invasive blood pressure monitors market are GE Healthcare, SOMNOmedics, Eccosur SA, Koninklijke Philips N.V., Huntleigh Technology Ltd., Mortara Instrument, Schiller Americans Inc., American Diagnostic Corporation and Welch Allyn.

GE Healthcare:

Overview:

GE Healthcare is a subsidiary of the American multinational conglomerate General Electric Company. The company manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures as of 2017. Dyes for magnetic-resonance imaging methods are available from the firm. GE Healthcare also manufactures medical diagnostic equipment, including CT image machines. Moreover, it develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. The company is operated in more than 100 countries.

Product Portfolio:

CRITIKON SOFT-CUF Blood Pressure Cuffs: CRITIKON SOFT-CUF is made of soft, absorbent material with rounded corners to maximize patient comfort during long hospital stays. These cuffs are ideal for patients with longer-term stays or protocols in which the cuff travels with the patient throughout their stay. It can be cleaned and reused on multiple patients. Still, it is reasonably priced so that it can be discarded after single-patient use, allowing for preventing infections more affordably.

The global non-invasive blood pressure Monitors market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Ongoing research for non-invasive blood pressure monitors is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Drawbacks of non-invasive blood pressure measurements are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Automated BP Monitors*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Ambulatory BP Monitors
  • 7.4. Sphygmomanometers
  • 7.5. BP Transducers

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital*
      • 8.2.1.1. Introduction
      • 8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Aneroid
  • 8.4. Wearable

9. By Accessory

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 9.1.2. Market Attractiveness Index, By Accessory
  • 9.2. Blood Pressure Cuffs*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Manometers
  • 9.4. Valves and Tubing
  • 9.5. Bulbs

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By End user
  • 10.2. Hospitals*
      • 10.2.1.1. Introduction
      • 10.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Clinics
  • 10.4. Ambulatory Surgical Center
  • 10.5. Home Care Setting
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Accessory
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. GE Healthcare*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. SOMNOmedics
  • 13.3. Eccosur SA
  • 13.4. Koninklijke Philips N.V.
  • 13.5. Huntleigh Technology Ltd.
  • 13.6. Mortara Instrument
  • 13.7. Schiller Americans Inc.
  • 13.8. American Diagnostic Corporation
  • 13.9. Welch Allyn

LIST NOT EXHAUSTIVE

14. Global Non-Invasive Blood Pressure Monitors Market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us